Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhou Lin
Anti-Igf-1r Monoclonal Antibody Inhibits the Carcinogenicity Activity of Acquired Trastuzumab-Resistant SKOV3
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Energetics and Couplings in Oligoacene-Based Singlet Fission: Efficient and Accurate Density Functional Theory Tells the Story
Related publications
Safety, Tolerability, and Pharmacokinetics of the Anti-Igf-1r Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Humanised Anti-Igf-1r Monoclonal Antibody (AVE1642) Enhances Bortezomib-Induced Apoptosis in Myeloma Cells Lacking CD45
British Journal of Cancer
Cancer Research
Oncology
T-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
Anti-Antibody Activity of a Monoclonal Macroglobulin
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Initial Testing of a Monoclonal Antibody (IMC-A12) Against IGF-1R by the Pediatric Preclinical Testing Program
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Beta-Adrenergic Agonist Activity of a Monoclonal Anti-Idiotypic Antibody.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1
Cancer Letters
Cancer Research
Oncology
IGF-1R as an Anti-Cancer Target--Trials and Tribulations
Chinese Journal of Cancer
